Homepage
Author:
METiS TECHNOLOGY
Posted Date:
May 20, 2026
METiS TechBio to Present Late-Breaking Data on Near-Complete Cardiomyocyte Delivery at CRS 2026
METiS TECHNOLOGY
May 20, 2026
METiS TechBio, the World’s First Publicly Listed AI-Powered Drug Delivery Company, Debuts on the Hong Kong Stock Exchange, “The SpaceX of Pharmaceuticals” Ushers in a New Era of Biopharmaceuticals
METiS TECHNOLOGY
May 13, 2026
